The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Molecular Diagnostics For Sexually Transmitted Diseases Market Over The 2026–2030 Period?
The market size for molecular diagnostics focused on sexually transmitted diseases has witnessed rapid expansion in recent years. This sector is anticipated to increase from $3.67 billion in 2025 to $4.07 billion in 2026, at a compound annual growth rate (CAGR) of 10.7%. In the past, this growth was influenced by factors including a reliance on conventional serological tests, the constrained availability of automated PCR systems, inadequate awareness of molecular diagnostics in nascent markets, a rising incidence of sexually transmitted infections, and testing processes characterized by manual workflows and intensive labor.
The molecular diagnostics for sexually transmitted diseases market size is projected to experience rapid growth in the coming years, with forecasts indicating it will reach $6.05 billion in 2030, driven by a compound annual growth rate (CAGR) of 10.4%. This expansion during the forecast period can be attributed to advancements in automated PCR and nucleic acid extraction technologies, the broadening availability of point-of-care molecular diagnostics, improvements in healthcare infrastructure across developing regions, the increasing adoption of laboratory information management systems (LIMS), and growing investment in research and development for rapid and multiplexed diagnostic assays. Key trends anticipated in the forecast period include the escalating use of nucleic acid-based testing methods, the proliferation of point-of-care molecular diagnostic solutions, an increasing demand for quick and accurate STD detection, the integration of molecular diagnostics with laboratory information systems, and the advancement of automated PCR and high-throughput diagnostic platforms.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27351&type=smp
What Underlying Factors Are Accelerating The Growth Of The Molecular Diagnostics For Sexually Transmitted Diseases Market?
The escalating incidence of sexually transmitted infections is projected to advance the molecular diagnostics for sexually transmitted diseases market in the coming years. Sexually transmitted infections (STIs) refer to health conditions caused by bacteria, viruses, or parasites that are transmitted through sexual contact, affecting the reproductive and urinary systems. The increasing prevalence of STIs largely stems from the inconsistent application of protection methods, which in turn facilitates the easier spread of infections among sexually active individuals. Molecular diagnostics for sexually transmitted infections (STIs) play a vital role in managing these conditions by enabling the early and precise identification of pathogens, even in asymptomatic cases, thereby allowing for timely treatment, reducing disease transmission, and enhancing overall patient recovery. For instance, in June 2024, according to the UK Health Security Agency (UKHSA), England recorded 401,800 new STI diagnoses in 2023, an increase of 4.7% compared to the 383,789 cases reported in 2022. Therefore, the rising prevalence of sexually transmitted infections is a key driver for the growth of the molecular diagnostics for sexually transmitted diseases market.
How Is The Molecular Diagnostics For Sexually Transmitted Diseases Market Segmented Across Key Categories?
The molecular diagnostics for sexually transmitted diseases market covered in this report is segmented –
1) By Product: Instruments And Services, Consumables, Software
2) By Technology: Laboratory Testing, Point-Of-Care Testing
3) By Application: Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications
Subsegments:
1) By Instruments And Services: Molecular Diagnostic Analyzers, Automated Polymerase Chain Reaction Systems, Nucleic Acid Extraction Instruments, Diagnostic Service Providers, Maintenance And Calibration Services, Installation And Training Services
2) By Consumables: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Nucleic Acid Probes, Control And Reference Standards, Detection Enzymes And Buffers
3) By Software: Data Interpretation And Reporting Software, Polymerase Chain Reaction Workflow Management Software, Laboratory Information Management Systems, Diagnostic Decision Support Software, Quality Control Monitoring Software
Which Upcoming Trends Are Expected To Influence The Molecular Diagnostics For Sexually Transmitted Diseases Market?
Major corporations within the molecular diagnostics for sexually transmitted diseases market are prioritizing the development of innovative solutions, such as rapid point-of-care polymerase chain reaction (PCR) devices, to enhance diagnostic speed, accuracy, and accessibility. These rapid point-of-care PCR devices are portable molecular diagnostic tools that integrate sample preparation, amplification, and detection into a single, compact unit, allowing for timely and highly sensitive pathogen detection outside traditional laboratory settings. For instance, in March 2025, Visby Medical, a US-based diagnostic technology company, introduced the Visby Medical Women’s Sexual Health Test. This product is a single-use, handheld PCR device engineered to identify chlamydia, gonorrhea, and trichomoniasis from vaginal samples within 30 minutes. It operates without the need for external instrumentation or cold-chain logistics, incorporates an integrated amplification system, and provides lab-quality results directly at the point of care to support immediate clinical decisions. The test is authorized for prescription home use, making it the first U.S. Food and Drug Administration (FDA)-cleared molecular diagnostic test for multiple sexually transmitted infections (STIs) that can be utilized outside clinical settings. This launch signifies a transition towards decentralized diagnostic solutions that broaden accessibility, especially for underserved or remote populations.
Who Are The Dominant Players Shaping The Molecular Diagnostics For Sexually Transmitted Diseases Market Landscape?
Major companies operating in the molecular diagnostics for sexually transmitted diseases market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Hologic Inc., bioMérieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, Solone Life Sciences India (P) Ltd.
Read the full molecular diagnostics for sexually transmitted diseases market report here:
Which Region Is Projected To Dominate The Molecular Diagnostics For Sexually Transmitted Diseases Market During The Forecast Period?
North America was the largest region in the molecular diagnostics for sexually transmitted diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics for sexually transmitted diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Molecular Diagnostics For Sexually Transmitted Diseases Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27351&type=smp
Browse Through More Reports Similar to the Global Molecular Diagnostics For Sexually Transmitted Diseases Market 2026, By The Business Research Company
Trade Credit Insurance Market Report 2026
https://www.thebusinessresearchcompany.com/report/trade-credit-insurance-global-market-report
Household Insecticides Market Report 2026
https://www.thebusinessresearchcompany.com/report/household-insecticides-global-market-report
Household Lending Market Report 2026
https://www.thebusinessresearchcompany.com/report/household-lending-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model